Study characteristics | Patients’ characteristics | In-hospital complications | Six-month outcome | Twelve-month outcome |
Lead author, title and year of publication, journal, study design, setting and location, sample size and length of follow-up. | Age, ethnicity, obstetric history, comorbidities, clinical presentation, electrocardiography, echocardiography, biomarkers and treatment. | Death, arrhythmias (eg, AF, VT) or thromboembolism (eg, DVT, PE, LV thrombus, stroke, arterial embolism), LV assist device, pacemaker, invasive ventilation, acute kidney injury. | Death, readmission to hospital, LV non-recovery (persistent LV dilatation and/or LVEF <50%), arrhythmias (eg, AF, VT) or thromboembolism (eg, DVT, PE, LV thrombus, stroke, arterial embolism). | Death, readmission to hospital, LV non-recovery (persistent LV dilatation and/or LVEF <50%), arrhythmias (eg, AF, VT) or thromboembolism (eg, DVT, PE, LV thrombus, stroke, arterial embolism). |
AF, atrial fibrillation; DVT, deep vein thrombosis; LV, left ventricular; LVEF, LV ejection fraction; PE, pulmonary embolism; VT, ventricular tachycardia.